Lung Cancer

Lung cancer is broadly classified into two main types: non-small cell lung cancer (NSCLC), which accounts for the majority of cases, and small cell lung cancer (SCLC), which is less common but tends to grow and spread more aggressively. NSCLC includes subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, each with distinct biological behavior and treatment approaches.

The most significant risk factor for lung cancer is tobacco smoking, including cigarettes, cigars, and pipes, as well as exposure to secondhand smoke. Other risk factors include exposure to radon gas, asbestos, air pollution, certain industrial chemicals, and a family history of lung cancer. Importantly, lung cancer can also occur in individuals who have never smoked.

Symptoms often develop gradually and may not appear until the disease is advanced. Common signs include a persistent cough, coughing up blood, chest pain, shortness of breath, unexplained weight loss, hoarseness, and recurrent respiratory infections. Because these symptoms can mimic other conditions, early detection requires careful clinical evaluation.

Diagnosis typically involves imaging studies such as chest X-rays and CT scans, followed by confirmatory testing through biopsy of lung tissue or fluid. Additional molecular testing is often performed to identify genetic mutations or biomarkers that can guide targeted treatment decisions. Staging is essential to determine the extent of disease spread and to guide therapy.

Treatment depends on the type and stage of lung cancer and may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Early-stage non-small cell lung cancer may be treated with surgery alone or combined with other therapies, while advanced disease often relies on systemic treatments to control progression and improve quality of life.

Recent advances in precision medicine have transformed lung cancer care, particularly through drugs that target specific genetic mutations such as EGFR, ALK, and ROS1. Immunotherapy has also become a major treatment option, helping the immune system recognize and attack cancer cells more effectively. These innovations have improved survival for many patients with advanced disease.

Living with lung cancer can involve physical, emotional, and practical challenges, requiring a multidisciplinary approach to care. Supportive services such as pulmonary rehabilitation, nutritional counseling, pain management, and psychological support play a critical role in maintaining quality of life. With ongoing research and earlier detection efforts, outcomes continue to improve for many patients and families.

Publisher - Xspurts.com

Language - English

Perfect Bound

Contributors

By author

Wyatt U. Sinclair

Published Date - 2026-05-26

ISBN - 9781776830145

Dimensions - 19.7 x 13.2 x 1.1 cm

Page Count - 200